(Q53460735)

14 May 2018

title

Unrelated cord blood transplantation in children with idiopathic severe aplastic anemia. (English)

1 reference

14 May 2018

author name string

K W Chan

1

1 reference

14 May 2018

L McDonald

2

1 reference

14 May 2018

D Lim

3

1 reference

14 May 2018

M S Grimley

4

1 reference

14 May 2018

G Grayson

5

1 reference

14 May 2018

D A Wall

6

1 reference

14 May 2018

language of work or name

English

0 references

publication date

11 August 2008

1 reference

14 May 2018

Bone Marrow Transplantation

published in

1 reference

14 May 2018

volume

42

1 reference

14 May 2018

issue

9

1 reference

14 May 2018

page(s)

589-595

1 reference

14 May 2018

https://scigraph.springernature.com/pub.10.1038/bmt.2008.227

exact match

0 references

cites work

Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survival

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.227

Long-term outcome of acquired aplastic anaemia in children: comparison between immunosuppressive therapy and bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.227

Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.227

Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.227

Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.227

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.227

Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.227

Umbilical-cord blood cell transplantation conditioned with a reduced intensity-regimen is a practical salvage therapy for severe aplastic anemia refractory to immunosuppressive therapy with antithymocyte globulin/ciclosporin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.227

Transplantation of highly purified CD34+ progenitor cells from alternative donors in children with refractory severe aplastic anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.227

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.227

Bone marrow transplantation in children with severe aplastic anemia using a conditioning regimen containing 3 Gy of total body irradiation, cyclophosphamide with or without antithymocyte globulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.227

Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.227

Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.227

Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Bl

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.227

Advances in HLA: practical implications for selecting adult donors and cord blood units

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.227

Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.227

Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.227

Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.227

Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.227

Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.227

Retreatment with rabbit anti-thymocyte globulin and ciclosporin for patients with relapsed or refractory severe aplastic anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.227

7 January 2021

Prospective multicenter trial comparing repeated immunosuppressive therapy with stem-cell transplantation from an alternative donor as second-line treatment for children with severe and very severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.227

7 January 2021

Recent improvement in outcome of unrelated donor transplantation for aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.227

7 January 2021

Guidelines for the diagnosis and management of acquired aplastic anaemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.227

7 January 2021

National Marrow Donor Program HLA-matching guidelines for unrelated marrow transplants

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.227

7 January 2021

Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.227

7 January 2021

Outcomes among 562 recipients of placental-blood transplants from unrelated donors

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.227

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.227

7 January 2021

Sustained and stable hematopoietic donor-recipient mixed chimerism after unrelated cord blood transplantation for adult patients with severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.227

7 January 2021

Umbilical cord blood transplant in hepatitis C-associated severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.227

7 January 2021

Effective donor lymphohematopoietic reconstitution after haploidentical CD34+-selected hematopoietic stem cell transplantation in children with refractory severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.227

7 January 2021

Feasibility and results of bone marrow transplantation from an HLA-mismatched unrelated donor for children and young adults with acquired severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.227

7 January 2021

Identifiers

DOI

10.1038/BMT.2008.227

1 reference

14 May 2018

1 reference

14 May 2018